Voom Medical Devices
Debt Financing in 2025
Voom Medical Devices specializes in manufacturing innovative orthopedic medical devices and appliances, primarily focused on minimally invasive surgery for the foot and ankle. Their product portfolio includes orthopedic devices designed to surgically repair bunions while preserving a range of motion, aiming to enhance patients' quality of life. Additionally, they provide tools to facilitate bone surgery, enabling healthcare professionals to improve surgical efficiency.
Spectral AI develops proprietary AI algorithms and optical technology to predict wound healing. Its DeepView® Wound Imaging Solution, an FDA Breakthrough Designated system, uses multispectral imaging to distinguish between non-healing and healing tissue invisible to the naked eye. The company aims to provide 'Day One' healing assessments for burn wounds and diabetic foot ulcers.
Proscia Inc., established in 2014 and headquartered in Philadelphia, Pennsylvania, specializes in digital pathology informatics through its innovative cloud-based platform. This platform aids in routine pathology operations, enhances cancer diagnosis, and seeks to improve patient outcomes. By leveraging advanced computing technologies, Proscia's solution unlocks hidden data that is not discernible to the human eye, transforming that information into valuable insights. These insights support physicians in accelerating the development of life-saving medical advances, ultimately contributing to a more effective diagnostic process in the field of pathology.
CalciMedica is a biopharmaceutical company focused on developing therapeutics for inflammatory and autoimmune disorders. It specializes in discovering and developing small molecule drugs that target calcium release-activated calcium channels.
Men in Blazers
Series A in 2025
Men in Blazers is a U.S.-based media company specializing in soccer coverage. It produces engaging content, including podcasts and TV shows, focused on major international leagues like the Premier League and Champions League, as well as U.S. national teams and the National Women's Soccer League. The company is known for its unique blend of humor, emotion, intelligence, and pop culture references in its coverage.
Mercury/13
Private Equity Round in 2024
Mercury/13, established in 2023, is a private equity firm specializing in acquiring equity stakes in European professional women's football teams. Its primary objective is to become a leading force in women's football ownership by strategically investing in and supporting the growth of future powerhouse clubs, thereby tapping into the vast, underserved market of women's football fans.
Unrivaled
Venture Round in 2024
Unrivaled operates a professional women's basketball league, providing an innovative platform for athletes during the WNBA offseason. The league offers competitive play and alternative income sources through its unique three-on-three full-court format.
Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene and biologic therapies to treat blinding diseases and retinal conditions. Its pipeline includes OCU200 for wet age-related macular degeneration, diabetic retinopathy, and diabetic macular edema; OCU400 for retinitis pigmentosa; and OCU410 for dry age-related macular degeneration. The company pursues a modifier gene therapy platform to address inherited and multifactorial retinal diseases such as retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease, and geographic atrophy. Ocugen maintains strategic partnerships for gene therapy co-development and manufacturing, including a collaboration with CanSino Biologics. In addition to retinal therapies, the company is pursuing regenerative cell therapy and vaccine platforms. Ocugen is headquartered in Malvern, Pennsylvania.
Epica International
Debt Financing in 2024
Epica International, Inc. specializes in designing, developing, and distributing innovative robotic systems that integrate advanced imaging technology and precision robotics. The company offers a range of products, including Vimago, a CT imaging and fluoroscopy device for veterinary diagnostics; Pegaso, a high-definition CT system for equine applications; and Artemis, a device for non-invasive regenerative therapy. Additionally, Epica provides Ortis, a robotic system for orthopedic carving, SandRob for surface processing needs, ScultoRob for milling artistic designs, and ARPP, a software for robotic simulation and control. Established in 2013 and headquartered in San Clemente, California, Epica serves various markets, including veterinary medicine, orthotics and prosthetics, and surface processing, aiming to enhance treatment outcomes through the integration of imaging and robotics.
Cosm
Venture Round in 2024
Cosm is a technology, media, and entertainment company that specializes in creating comprehensive solutions for immersive experiences across various sectors. The company develops a global platform that integrates physical design, engineering, manufacturing, software, and content delivery, enabling large-scale, live immersive entertainment. By focusing on areas such as sports, education, and attractions, Cosm aims to transform how individuals engage with entertainment through innovative technologies and experiences.
Cytosorbents is a critical care medical device company that develops and commercializes blood purification technologies. Its flagship product, CytoSorb, is an extracorporeal cytokine filter designed for adjunctive therapy in treating sepsis and other critical illnesses.
NSP
Debt Financing in 2024
NSP is a restaurant brand that specializes in providing franchising solutions for Burger King, KFC, and other fast-food restaurants.
PolarityTE
Debt Financing in 2024
PolarityTE, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, specializing in regenerative medicine. Founded in 2015, the company focuses on developing functionally polarized human tissues to enhance clinical medicine and biomedical research. PolarityTE's innovative technology platform enables the regeneration of tissues using the patient’s own cells, promoting natural healing processes. One of its flagship products, SkinTE, is designed to repair and regenerate skin for patients suffering from acute and chronic wounds, burns, and other conditions requiring surgical reconstruction. The company emphasizes the use of autologous tissue to create dynamic, self-propagating products that facilitate effective regenerative healing, thereby transforming the landscape of tissue engineering and regenerative therapies.
ProducePay
Series D in 2024
ProducePay, founded by Pablo Borquez Schwarzbeck, is an AgTech company dedicated to transforming the fresh produce supply chain. By addressing the economic and food waste caused by its volatility and fragmentation, ProducePay offers a Predictable Commerce Platform that enhances connectivity between growers and buyers. This platform provides farmers with immediate access to financing, liquidity, and real-time pricing data, fostering transparency and enabling efficient business operations. Additionally, it facilitates connections with key industry players, allowing farmers to access tailored cash flow services. Through these innovations, ProducePay is committed to delivering fresher produce to consumers while promoting sustainable practices within the global fresh produce industry.
ITS Technology Group
Debt Financing in 2023
ITS Technology Group specializes in designing, building, and operating full fiber and fixed wireless networks. They provide proactive IT managed services and hosted telephony solutions, focusing on hard-to-reach rural and urban businesses.
Beyond Air is a biotechnology company focused on developing nitric oxide (NO) therapies for treating lung infections and other respiratory conditions. Its proprietary LungFit system generates and delivers NO to both intubated and non-intubated patients in hospitals and home settings, aiming to improve patient outcomes while reducing the need for cylinders.
Eyenovia is a clinical-stage biopharmaceutical company focused on transforming ocular drug delivery for prominent eye diseases. Utilizing its proprietary piezo-dispersion and microdosing technology, Eyenovia develops next-generation topical eye treatments designed to reduce toxicity and improve safety profiles.
Kin Insurance
Debt Financing in 2022
Kin Insurance, Inc. is a digital insurance agency that specializes in homeowners insurance and related products. Founded in 2016 and headquartered in Chicago, Illinois, with an additional office in St. Petersburg, Florida, the company aims to enhance the convenience and affordability of insurance by operating directly with consumers, eliminating the need for external agents. Kin Insurance offers a variety of products, including homeowners, mobile home, condo, flood, and landlord insurance, among others. The company leverages extensive property data to ensure precise pricing and improve underwriting outcomes, providing personalized coverage options and efficient claims services through its technology-driven platform.
Oliver Space
Series B in 2022
Founded in San Francisco in 2018 by Chan Park, Oliver Space is a home furnishing company that simplifies and affords living space customization. It offers a wide range of products from sofas to plants on a flexible rent or buy basis, with a unique try-before-you-buy option at 0% interest.
Enerkem
Debt Financing in 2022
Enerkem transforms non-recyclable waste into renewable biofuels and chemicals. Its proprietary thermochemical process converts municipal solid waste into biofuels like ethanol, addressing oil dependence and waste disposal challenges.
Aytu BioPharma
Post in 2022
Aytu BioPharma is a specialty pharmaceutical company focused on developing and commercializing prescription therapeutics and consumer health products. Its primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions.
Intellihot
Venture Round in 2021
Intellihot is a manufacturer of tankless water heater systems for both residential and commercial applications. Established in 2005, the company emerged from the founder's experience with a traditional water heater malfunction. Intellihot's innovative designs, which have several patents pending, focus on conserving space and eliminating the need for bulky storage tanks. The systems are equipped with advanced connectivity features, including Wi-Fi and 3G/4G capabilities, allowing users to connect to a router or internet hub. This connectivity enables the analysis of water usage patterns, providing clients with on-demand water heating solutions that are both efficient and space-saving.
BioVie is a Santa Monica-based clinical-stage biotechnology company focused on developing therapies for liver disease and related conditions, and on select neurological and neurodegenerative disorders. The company is advancing BIV201 for ascites due to chronic liver cirrhosis, with a Phase 2a trial completed, and developing NE3107 for Alzheimer's disease, pursuing a pivotal Phase 3 study in mild to moderate cases. Founded in 2013 and formerly known as NanoAntibiotics, BioVie translates scientific discovery into therapies aimed at improving outcomes in serious liver and neurodegenerative diseases.
Netomnia
Debt Financing in 2021
Netomnia is a fiber-to-the-premises (FTTP) broadband service provider based in London, England, established in 2019. The company focuses on constructing full-fiber broadband infrastructure and networks throughout the United Kingdom, aimed at connecting both homes and businesses. By offering symmetrical multi-gigabit services, Netomnia ensures that clients receive reliable internet speeds tailored to their specific requirements.
Delcath Systems
Post in 2021
Delcath Systems is an interventional oncology company specializing in the treatment of primary and metastatic liver cancers. Its proprietary product, Melphalan Hydrochloride for Injection used with the Delcath Hepatic Delivery System, enables high-dose chemotherapy administration directly to the liver while minimizing systemic exposure.
Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that deploys their patented therapies focused on the activation and rebalancing of the body’s immune system. Stimulating the body’s immune system remains one of the most promising approaches in the treatment of Cancers, HIV, Autoimmune Diseases, inflammatory conditions and other chronic infectious diseases.
Third Pole Therapeutics
Debt Financing in 2021
Third Pole Therapeutics, based in Waltham, Massachusetts, specializes in developing innovative, on-demand nitric oxide delivery systems for various medical applications. Their core technology generates pure, inhalable nitric oxide from air and electricity, eliminating the need for bulky gas cylinders. This system is equivalent to traditional tank-gas methods and has proven effective in treating hypoxic respiratory failure in newborns. The company aims to expand the accessibility of nitric oxide therapy, which is currently limited to certain countries and healthcare settings, to save lives and improve patient outcomes in conditions like malaria, heart attacks, and strokes.
Zorin Finance
Debt Financing in 2020
Zorin Finance is a real estate lender established in 2011 and headquartered in London, United Kingdom. The company specializes in offering development finance and bridge loans specifically tailored for real estate developers operating within the UK market. By focusing on the needs of the real estate sector, Zorin Finance aims to support developers in achieving their project goals through accessible and targeted financial solutions.
Castlehaven Finance
Private Equity Round in 2019
Castlehaven Finance is an alternative lender that specializes in funding property development projects throughout Ireland. The company provides a range of lending services, including senior development loans, bridge finance, and financing for residential, commercial, and mixed-use developments. Its focus is on supporting private, social, and commercial initiatives, ensuring that clients have access to flexible and reliable loan options tailored to their specific needs.
Asset Reconstruction Company (India)
Secondary Market in 2018
Established in Mumbai, Asset Reconstruction Company (India) specializes in acquiring and resolving non-performing financial assets from Indian banks and financial institutions. Since its inception, it has successfully resolved over Rs.780 billion worth of NPAs.
C.P. Crane
Acquisition in 2016
Owns and operates a coal-fired power plant near Baltimore
Ambow Education Holding
Series C in 2008
Ambow Education Holding is a Chinese education company that offers K‑12 schooling, tutoring, vocational training, and career‑enhancement programs. It operates a network of schools, tutoring centers, and training offices across the country, using a blended online‑offline model powered by proprietary technology. The firm has developed an AI‑driven hybrid digital classroom platform that integrates software and hardware to create interactive learning environments. Its services aim to help students gain admission to top secondary and post‑secondary institutions and to secure better employment after graduation. Founded in 2000 and headquartered in Beijing, the company has expanded to more than 60 centers and schools, serving students and corporate clients nationwide.
Wuxi Qiaolian Wind Power Technology
Series A in 2008
Wuxi Qiaolian Wind Power Technology Co. Ltd. is a manufacturer based in Wuxi, China, established in 2006. The company specializes in the design, research, and production of wind power equipment accessories, including rotor hubs, nacelle bases, girder systems, bearing cases, and pitch adjuster parts. In addition to wind power equipment, Wuxi Qiaolian also focuses on the manufacture of CNC and general-purpose machine tools, as well as metallurgical equipment. The company's diverse offerings position it as a key player in the renewable energy sector, contributing to the advancement of wind power technology.
Ambow Education Holding
Series B in 2007
Ambow Education Holding is a Chinese education company that offers K‑12 schooling, tutoring, vocational training, and career‑enhancement programs. It operates a network of schools, tutoring centers, and training offices across the country, using a blended online‑offline model powered by proprietary technology. The firm has developed an AI‑driven hybrid digital classroom platform that integrates software and hardware to create interactive learning environments. Its services aim to help students gain admission to top secondary and post‑secondary institutions and to secure better employment after graduation. Founded in 2000 and headquartered in Beijing, the company has expanded to more than 60 centers and schools, serving students and corporate clients nationwide.